why choose us

First received: December 6, 2022

Clinical Trial: Characteristics of Patients Treated With Secukinumab for Moderate to Severe Plaque Psoriasis

Study Status: Completed

Recruit Status: Completed

Condition: Plaque Psoriasis

Study Type: Observational


Official Title: The Characteristics of Patients Treated With Secukinumab for Moderate to Severe Plaque Psoriasis in Real-world Practice in Thailand

Brief Summary: This study was a non-interventional, retrospective study collecting data from hospital medical records. Approximately 200 adult patients with moderate to severe plaque psoriasis who were treated with secukinumab from hospitals in Thailand that participated in this study were expected for data collection.

Read more